Received: from VE1PR01MB12340.eurprd01.prod.exchangelabs.com (2603:10a6:20b:6fd::17) by GVXPR01MB11722.eurprd01.prod.exchangelabs.com with HTTPS; Tue, 10 Mar 2026 09:55:43 +0000 ARC-Seal: i=2; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=pass; b=Au0gzMQID7WJ2noO63UHKIkpp9u69UXhPDJsTo897/gmq/OTSsc5KX0n5iSTbNCGS053VLiZ6kDLIREI+YGe4r5aHNnUQhKTb9tws9TiCJ4yPqkzkUGsA73kIvJ5reViW7hhCDIZEdvGqbYbEKG9IlFBYtf5PNDRB2QZyFRRDt2yrJ5qp4IRgK9q7cNIC3aLN8JDZE9LUSWN+xAXUIQ2hwcJba6u6GrbUxOCfPi4py5jHX3NEaaV1HGnJTTyjt0QE6lqgZ/lAIxBemF9H7e7+a/chJsMwKcYidxUHhY30rv3mYfmMf3WBjZ/eS8NmYcJKUkijYRueNhHFr0o6/w49g== ARC-Message-Signature: i=2; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=kt6h+wEP+z4ZiAa6PZpPCC8Aw/XHaSkdAg+pdXLnQ6U=; b=FiwDFnDQsCm0NcfSzPUfPGCw5K50/PTGeJtzVhy/JOLLQMkerihHTXrqNFlX5+LEZqFrlfaSmaRRWp/83hDbeluJHJcYJdSdlgrtXEbyfZxzSdFOsFlORUXvf065Nl0/TNssWqmY/JdVm20EXRzVyzRx1OfOaraiB2Y6YX5UCNRUkjPRjBP6DtuscLBwfIWsP0sZy7xmXRetwYubVNy4ExTcsmY5W5jq1C6xFx0QgH1CrDCXCrtMkMBf+VejWQVynlL1brnjMJDwhkmlpFsvOVTemp22iiUdtk6/sbJxSgSyWXYObJ8spQrEZZ/mi2zZEadZUqqLtMgLycIJ0PgYsg== ARC-Authentication-Results: i=2; mx.microsoft.com 1; spf=pass (sender ip is 2a01:111:f403:c205::3) smtp.rcpttodomain=warwick.ac.uk smtp.mailfrom=hra.nhs.uk; dmarc=pass (p=reject sp=reject pct=100) action=none header.from=hra.nhs.uk; dkim=pass (signature was verified) header.d=hra.nhs.uk; arc=pass (0 oda=1 ltdi=1 spf=[1,1,smtp.mailfrom=hra.nhs.uk] dkim=[1,1,header.d=hra.nhs.uk] dmarc=[1,1,header.from=hra.nhs.uk]) Received: from AM5PR0601CA0058.eurprd06.prod.outlook.com (2603:10a6:206::23) by VE1PR01MB12340.eurprd01.prod.exchangelabs.com (2603:10a6:20b:6fd::17) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9678.25; Tue, 10 Mar 2026 09:55:46 +0000 Received: from AM4PEPF00027A62.eurprd04.prod.outlook.com (2603:10a6:206:0:cafe::74) by AM5PR0601CA0058.outlook.office365.com (2603:10a6:206::23) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9678.25 via Frontend Transport; Tue, 10 Mar 2026 09:55:47 +0000 Authentication-Results: spf=pass (sender IP is 2a01:111:f403:c205::3) smtp.mailfrom=hra.nhs.uk; dkim=pass (signature was verified) header.d=hra.nhs.uk;dmarc=pass action=none header.from=hra.nhs.uk;compauth=pass reason=100 Received-SPF: Pass (protection.outlook.com: domain of hra.nhs.uk designates 2a01:111:f403:c205::3 as permitted sender) receiver=protection.outlook.com; client-ip=2a01:111:f403:c205::3; helo=LO2P265CU024.outbound.protection.outlook.com; pr=C Received: from LO2P265CU024.outbound.protection.outlook.com (2a01:111:f403:c205::3) by AM4PEPF00027A62.mail.protection.outlook.com (2603:10a6:20f:fff4:0:4:0:7) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9678.18 via Frontend Transport; Tue, 10 Mar 2026 09:55:46 +0000 ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=nokJC+ne7QaWmxQL3fzqCZl5xMI30IVWunj4eLDS4pa2xe+uBpfxY8sALzIWwnUBrwcFCeKuZNTqlaIv9EGaBm0wt55KCrqV3rJgLP6W3gBEOKLDx6Wcs6Lp153xdS4421Gi78zL68ZFowUBbuDU1PeYjT6gmMT2xG/O979KU9Zj6W1NzRWKT7vDn/AAjT/wBmyfrmYQO+C7Lb60ZtfWCu3YgK48V6bxUZOb72YUtI22MakJn/AMe8C0x59NwQ5Wyd7UVJKVBtZoTGy2WU/XtLb25NhCFnxealbd3Xu7Zf3QsGAK1twoNGqFcNFuK1XI+j72l0GI44b36JdYjMuaaw== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=kt6h+wEP+z4ZiAa6PZpPCC8Aw/XHaSkdAg+pdXLnQ6U=; b=SMSnOrcP4guKjn/xI9catWGK3UrdcSmajF1WuM51G+laGsbJwNYr0D1Brk/+caJAH83VEfbqfs/Yuz6h9aZGkSyEQ06dKFBrvWbnkDUK9sFaDa6fo1b/Yxqh3Mxm4QKOGfEaPqm9UNsDrzneyq292ULb5sdAeHK9Ei3yJZ4BxLzeQOcmHPlD52tFx5CrBkVCfH1CMIVW3MyzajPLlQN+eRXll2b3NqxWQvAatozQFBgGblu8CwzsGoCzEBqAVxjnzCx6FPNf3ARHotLzmIGaPxfs4zx1dXGypn+xqmsyUpp0Yd3TKuS8ue6h717/hefr1Hk+EI+e7WAPCe9+PrvnZA== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=hra.nhs.uk; dmarc=pass action=none header.from=hra.nhs.uk; dkim=pass header.d=hra.nhs.uk; arc=none DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=hra.nhs.uk; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=kt6h+wEP+z4ZiAa6PZpPCC8Aw/XHaSkdAg+pdXLnQ6U=; b=iF7QFZOjWDQcAPRwmqbt/T+u+KPN8T809vO0ehpF4HtYvsYwYrpymidTgWVh25isc+7AvOM7z/9e7+kIPr2Ad+zgNf1v3/2ZMQxzlcsHGkXm0+1WEg1oeKcLQEgpnuU00oRyB3paQpH4WaK2DQL1LptuVAvzZqyQ9pEWmTwM6ZV2xyS+ol6e41/oCfqA5zrQarOQcCAx4X6c/AClafOC4HLcjKxq04RyumPMFf/Z/1GuLv0jBSTFgv77f4d2Y46a2ZwZONu1kdTh+7b1Kf9iSNNF9Z+ItnB7gRMDt5A6I3lLexY9N/feUWtPJcG1151d+GRzJjJWh0YN6x251lvl9w== Received: from LO0P302MB0209.GBRP302.PROD.OUTLOOK.COM (2603:10a6:600:365::10) by LO0P302MB1757.GBRP302.PROD.OUTLOOK.COM (2603:10a6:600:408::18) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9678.25; Tue, 10 Mar 2026 09:55:44 +0000 Received: from LO0P302MB0209.GBRP302.PROD.OUTLOOK.COM ([fe80::ceb2:f3cc:ba12:542a]) by LO0P302MB0209.GBRP302.PROD.OUTLOOK.COM ([fe80::ceb2:f3cc:ba12:542a%4]) with mapi id 15.20.9678.024; Tue, 10 Mar 2026 09:55:44 +0000 From: no-reply-IRAS To: "sis@warwick.ac.uk" Subject: IRAS 316755. Amendment Thread-Topic: IRAS 316755. Amendment Thread-Index: AQHcsHQP32I18c2xHEuvH/94ebYuug== Date: Tue, 10 Mar 2026 09:55:44 +0000 Message-ID: Accept-Language: en-GB, en-US Content-Language: en-US X-MS-Has-Attach: X-MS-TNEF-Correlator: Authentication-Results-Original: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=hra.nhs.uk; x-ms-traffictypediagnostic: LO0P302MB0209:EE_|LO0P302MB1757:EE_|AM4PEPF00027A62:EE_|VE1PR01MB12340:EE_|GVXPR01MB11722:EE_ X-MS-Office365-Filtering-Correlation-Id: dc66b102-9a97-421e-c745-08de7e8b33bc x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|19092799006|1800799024|366016|376014|38070700021|8096899003; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:LO0P302MB0209.GBRP302.PROD.OUTLOOK.COM;PTR:;CAT:NONE;SFS:(13230040)(19092799006)(1800799024)(366016)(376014)(38070700021)(8096899003);DIR:OUT;SFP:1101; X-MS-Exchange-AntiSpam-MessageData-Original-ChunkCount: 1 X-MS-Exchange-AntiSpam-MessageData-Original-0: =?us-ascii?Q?8qEO8tRr0CGuh6M9/RfbL+z5LteQJuUR1K5YSVRYyfxDdqnDqBpayZlPmMDS?= =?us-ascii?Q?uK7duFsL7zcF3oFH5AXPHRtjbEdmesJlIVnWVsvJz9tJi9z3GZCKegb5Y1m1?= =?us-ascii?Q?v7x/82tT76gSVcgr74qg2IXGuEMg/dHta3i3f4KNTeKMIWHpoelrvX5zz5d2?= =?us-ascii?Q?9n+ct6Cm/4XogehVgh9PFNvHh9YrUF+cdAsMRqgMlJ7vMnaD0Q3Ja3ZkvO0M?= =?us-ascii?Q?WXRPmRt/lfN3ZLlZb8VSZwqIkScX6LAHEzP6oqi6utnJEeeo/sNxYFvkbIRv?= =?us-ascii?Q?kW4uQvMAd86zEygk/rURDI9FLv+JOUc6vVcGYUSqLMfHberj0BWgOeN0HI2C?= =?us-ascii?Q?NFMcQD4FYs6ZnTyWJ89/7kqQs5ooF/GgFfjsIG+X1hI90wKW1GioURllNqFZ?= =?us-ascii?Q?JIoMR/bIfO8N6mhksufO0ZSIR05CtkzRXp+zQZ+yH7bBEfxssawWdnAkNGC/?= =?us-ascii?Q?+5uSzEjDlurzKLrQKk3w/AsCsThNVJGX4VJbJxS0RbN/G25GciLJSk02qIM6?= =?us-ascii?Q?W0rHxohg+WnKgYsMIT4DJDd7F1oDBTqySnZHcrJiC6CDcB05a1IGUJB7qsFP?= =?us-ascii?Q?/TZb29VwZTXA+Zj+tluLQKQOsdG3j3wuaQtZngQY/FsSokXIP8mDK3WoAi0U?= =?us-ascii?Q?RZ+k0QDXo0BoqGok410XKOvS69L3OpqUem+U1Xm5xYFUxAc7ggYyu+O4yXPp?= =?us-ascii?Q?Qy7d8FKhSClpULSriB9p+7JVWpjK7ZagHbHhHLZNXjpGdGYSkp7Tu8ug8ibW?= =?us-ascii?Q?dMx6iG3P47xBo4pdGnGOb7dXGQe0PofmshQ3a3zsM9hVYJvXZR/gAojg/X5M?= =?us-ascii?Q?DKo0QusyZqwpMyx/L3mRynKGGUS8tyTm+G2rV2Im2YnL4mM9WpMO8mYHJ4KB?= =?us-ascii?Q?5+GMzXsL2AvD6OPwEoz/kqRd3S/9d+Hgyg2jRLWxsOm98MSSaQZFTdkKNfd1?= =?us-ascii?Q?vZGmoNlW2oBo5FAB6yZQW9hQa3cXaISaKo+Ek0YC0N6cluOpr1U7FmBWAQmZ?= =?us-ascii?Q?5lPuAAVMp8owATc4OcLit8HW4WyjkP5wzEVpI6u5F7rlpFKUtbxUQ/eyXqat?= =?us-ascii?Q?RAO671l1VBdZsDM1WIVB3f7j8MXTIwNIe4SbNUbAzdsnrrNFucpmgstJMN3E?= =?us-ascii?Q?UZo53nrs6T0BYH+19frGTGgZTZgsJ9oXgtPiCC0fgPwc3L6y86IaAbOWqwLi?= =?us-ascii?Q?JlibqyB66rIvGfLR8N66YoE1z0/wFZWwRtRrKYwP6gJrsJCASxzfkU2/GmjV?= =?us-ascii?Q?FI/ippmVRMYJAHXCOBVmfVyPd4dUFjzJB1t+zkvDvJcN0ANkUolzWfKgK2yf?= =?us-ascii?Q?bYWhOkdVA6iXP9xF6E8VZmGBw88DWXJ8NlhSadqoYHYjrEWFfPtdfBtt9F/N?= =?us-ascii?Q?GHo1fX1boDykoibkbl/oRTtUIcMWSxatX5xmmADfAfHtPtb6gRtA9v7YReUg?= =?us-ascii?Q?/sF8gh9QIAEjrRNefupC7eMkkBIXMeLII1xTBlejESEXjm1viXC6ixiH1und?= =?us-ascii?Q?b6O1GZUxjfr8nB/o6RZRDgzywworzenpkSLcx8gIn4wITOiykRPS9s3IKB6w?= =?us-ascii?Q?svoBEBeZ0YXlNNOFV5FhbEPxjDG/FqChC1dS4gcitUI1YGYe1EPRP+7Xh1O2?= =?us-ascii?Q?v1AiNYgHDUxWwnYVYEYfh4IuROmN6FO9/MKh6aZJZ9K645Z5FHWWfCsSQPC+?= =?us-ascii?Q?dPfJj4Oxc3yrvje1Yvey9v17tT4/0SMpJzIDDWn3Mfb4KWpvN4btxUDQxODI?= =?us-ascii?Q?5I+vV27veb7VeRSVsQQjwZQ05sQI0j4=3D?= Content-Type: multipart/alternative; boundary="_000_LO0P302MB0209B0AFEC35D72FC5FFD4339046ALO0P302MB0209GBRP_" X-MS-Exchange-Transport-CrossTenantHeadersStamped: LO0P302MB1757 Return-Path: no-reply-iras@hra.nhs.uk X-MS-Exchange-Organization-ExpirationStartTime: 10 Mar 2026 09:55:46.6752 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: dc66b102-9a97-421e-c745-08de7e8b33bc X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 09bacfbd-47ef-4465-9265-3546f2eaf6bc:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-Exchange-Transport-CrossTenantHeadersStripped: AM4PEPF00027A62.eurprd04.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersPromoted: AM4PEPF00027A62.eurprd04.prod.outlook.com X-MS-PublicTrafficType: Email X-MS-Exchange-Organization-AuthSource: AM4PEPF00027A62.eurprd04.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id-Prvs: 8796b36e-c3ca-4199-c573-08de7e8b3236 X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|35042699022|12012899012|8096899003|54012099003; X-Forefront-Antispam-Report: CIP:2a01:111:f403:c205::3;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:LO2P265CU024.outbound.protection.outlook.com;PTR:mail-uksouthazlp170110003.outbound.protection.outlook.com;CAT:NONE;SFS:(13230040)(35042699022)(12012899012)(8096899003)(54012099003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 10 Mar 2026 09:55:46.6121 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: dc66b102-9a97-421e-c745-08de7e8b33bc X-MS-Exchange-CrossTenant-Id: 09bacfbd-47ef-4465-9265-3546f2eaf6bc X-MS-Exchange-CrossTenant-AuthSource: AM4PEPF00027A62.eurprd04.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: VE1PR01MB12340 X-MS-Exchange-Processed-By-BccFoldering: 15.20.9678.017 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930201)(20251009189)(140003)(1420198); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?R/peK63VsK51rHnkN/6MPSz5pS6yqHKynCPo6QHiYRacPGAJzA3E7U1ui6BR?= =?us-ascii?Q?Qfs+A6TfUwyoC6URFcVfS1khBr82g/co7elDgwRBF5l9z3MqP1FXegPkgdIY?= =?us-ascii?Q?DM+YjXZeeznPpRHvjP7SzthjUfyNljTW55gj2HNY/v2QaQJfEvKN0PKpnt8S?= =?us-ascii?Q?Cxmrr2cwcN5FrM/ZFl0w3H/Xies0mBHFaYNXPR0bwn3lWN+juXDYSJexQCMH?= =?us-ascii?Q?kad+fV1l0kH+Db+Kw80DbldFS2cnMWwMdSuYHB5jfUyhhCvNevuhhkCAraO0?= =?us-ascii?Q?U9mUCgNg2uu3x7BHXh1TmyRB47VZPDFf/uqq3pMzItDY31pmdziEnELKOs0g?= =?us-ascii?Q?fg+b0a7jqY0eufkIPVpVtNIpqaMqGOEXFjZpZ9Y4NhDfj2Itt7afXUIOVDJO?= =?us-ascii?Q?PQU2yoz1U+rj1JQR9Q+4/rkfxjM7dUunMUZ5W4lCwnA/8T8MjaeD/0k8K2XL?= =?us-ascii?Q?JEKRy5LCJY4KH5vVZqFtB0YZhBwUNVHaaE2Ju6Rv0oR7asj3KEQf0y3ZyvZy?= =?us-ascii?Q?tWLmsvzdwLeIIibxwLzpvKa39iABEv3U1yWAZJsAiPFKXxxJdsBoPGcPG0Zc?= =?us-ascii?Q?yOO8SdHFJaM6O9gYyuroMqHo/wnR4I9CJmLbHYmlI8BAFNkYP/q0vGyMrIaQ?= =?us-ascii?Q?fOHG44FytlMhE3AWroen9q/FFC4Ta8JEsWFbPUTprAKtlZERsVmmvarBWWTd?= =?us-ascii?Q?hjBePWVrVC088r3aKst3FH+s9C1D6NxYq6pgvQZLXOyo3cRuA69jnm7nm1RG?= =?us-ascii?Q?QQSki7x6NhY755leZmcLnXQpkm+AQ3+45m6BQl0fSFg+ogrga1Md3ksWj3aw?= =?us-ascii?Q?C0Hn50f7lqYdApWKS1SES8F61zKgBJj1Wd3drMazYhU1nCwqfOvaPb7ybCWq?= =?us-ascii?Q?3Qaii5q/+kkIBW5t/Y91LMlGI8y8AmzllJHIRMaYp2/QE7zcay07v/RtJbMP?= =?us-ascii?Q?tsp5aNGQrloiSS34S5CPTAdZTid6EKiRPS/b3nh2j4j9uyG3FnYeGeJQbelh?= =?us-ascii?Q?vBhVyS5+XX57zl+Y+qOKVKIbU5+b/Fd5UVGk15xD8LhgM5+Cv8qWUSKKLC+x?= =?us-ascii?Q?6BOlw7bwg+xi6dFi3KZoWj+3U+KWmlfn8G6DV9FdAemMJR5D+1mHp3NOfOlB?= =?us-ascii?Q?Hq3KnFckjqL5lHTVTuqeuPWPLHpIHSMAJ7IG2dcjJvxUgqQ+PEBllhaCmB/H?= =?us-ascii?Q?E+2FEQ4QPSubUH639A8a0EvAjeYv/VjgRX42YSINBUt2dqZr9WmDhI9sCU1h?= =?us-ascii?Q?R6o5l7mtBMNFJoUawOn6H0kiFxjGOjP73ahlm9J2NdIpZu6VdqAYyRpI0p/3?= =?us-ascii?Q?xNaZERJ9lre9iqE8NQYeot58BtG3KqyS5TOdWg5PSxSB+Jitdyc3Lw0y+art?= =?us-ascii?Q?lTZosP1ICBiTwV09HT9sim6l77aYUTc+e9vNlv0GpTEGxcjvOrFgQeNUH+Wt?= =?us-ascii?Q?UuAGWqHuINBmde8SFVpUuIQvd2ERTGpmjtqGiceIMBKf6IxNcB9crJahRzfF?= =?us-ascii?Q?D/7eIHpUozCwDgc/QiXeb/QXk8A86YGbX07kGB0oq0PBtuDq5rjPby3BGxpa?= =?us-ascii?Q?xbzD6QZzOWmc7U5tlFYxmTpxbyTIRqQxfSZWzpqD7ia2MtqyViRL4tiqtJhG?= =?us-ascii?Q?Dt23HPh4u0VVTmahjjPHA2CtLVOaoOBfIwpBWzh/YLbCI5kta9v7nCosAddt?= =?us-ascii?Q?BSkaNGjy4Ma37mZtxB9PDWvsVppzsA3vj1sO8f3P3PsIc5py8VDoMTdxwcV4?= =?us-ascii?Q?R4vXXG4+FQs4b8zRiNM0TPt9b9Ax7nrdsyVVN8qfdtL3s7k5t4VzNDZ/DoMy?= =?us-ascii?Q?pU6h7LEmCDIcXU2TyF8yEanOAbOXq8qBIhok3V5OuLBEQNNEkEBV+E44nUSO?= =?us-ascii?Q?MbPWIx49mz7i7UvAhpRxw5xaVlG4YB/QN9NqBJnAt6PmVjqQvIOLKjjRaFqE?= =?us-ascii?Q?+RhowlzF5XPHuyTJ1+zbqswoqMg023SAWbW6/0uRSRxbvSZporT8XIFd0sKJ?= =?us-ascii?Q?/a6b0R55eBF7DA0PV/0R26dXm1Cc4RHICGxpFy//8anvhcXnI8YhZTxw6XFA?= =?us-ascii?Q?7UZDwiyyy5W0wUAYWJ2ghSTLNNY5ygM1fgoAsiB6eBHT/5dnYnLE3pPdgJxa?= =?us-ascii?Q?X79Ta6zwc+T7pu1DWv2OS6mzrurhtVHjPzOLXln0zb/B+DBLDyk9tCDbQqd4?= =?us-ascii?Q?/YQ07zUTpDgY0TiBWgv3Cj1x1tV/MeiO25zkbDq2aki/ZZ9NYxJJRxiss1xY?= =?us-ascii?Q?+R/BUJi9gmjWQVAJKoRTbN2RCkLqocjw+htLWVLTZzTUw12yy5fClGz1OEls?= =?us-ascii?Q?2srRF0N9wvKElCETEp0IpieWAwdD60hmpyF9FOaFj6T5r9JIarvmw6oEDDm2?= =?us-ascii?Q?C56A7gUeJfqU1PfteaazqjpA/DRicYHAzVdGAjO+xpuFyTxy/SKAQPubPWz8?= =?us-ascii?Q?IPfRnC9bk5Q7V8WnziRa59YFyG5sDdTYPAV0x8YG1h7knhQpkFCDyW67iDq2?= =?us-ascii?Q?MXgW/jJN93xp/8LBPtNiBMR7kWnFtup3K+JAhOtFZEn2qP+K7u9OBU0q8ZHn?= =?us-ascii?Q?k+h0kDwLmsUl2Rs09sZU1JLMiGKp/MITVV1AZzRDnNvRnO4lkBQl7mbnVBP+?= =?us-ascii?Q?m5xg4o2q8oK8m+CVwqnC1lLO+2XqT0PDzR8tgmNZ8ktjD22GOa9oAbRzpXTg?= =?us-ascii?Q?6lWE5mMNbhP5pM2986qqFVBGYUPs+df1PDxSF3sW2vD0YT7jNhyYd/ASw6FW?= =?us-ascii?Q?oo4MGp2WCfZ8TNi62yFj60W2sBBc7I8PwtBRvGJR8c4xMzdAgGygDdvhdR7B?= =?us-ascii?Q?2imm2Uli2t35ue7sYF4KfhrVT6HBI8JWwgzLAX16wTapAPqlUkTCoLdiGOPT?= =?us-ascii?Q?DiHKas5cj8DefRphKd9W2Bkix2nxi4qMob+Adzz4OBwn6Rq9m4kQtjE6G7vI?= =?us-ascii?Q?Z48IZF4kws39KHHikdqWQFUqzO1KMlpRztjTeyLaLsP+JLvEPyoDEOnM+MLb?= =?us-ascii?Q?VvX6XC+gA2v72MCfic9B502e9t81Fgv2I9ZQYGIjaXgpelY=3D?= MIME-Version: 1.0 --_000_LO0P302MB0209B0AFEC35D72FC5FFD4339046ALO0P302MB0209GBRP_ Content-Type: text/plain; charset="us-ascii" Content-Transfer-Encoding: quoted-printable IRAS Project ID: 316755 Sponsor amendment reference: NSA24 Thank you for submitting your study amendment. In accordance with the outc= ome of your completed amendment tool, this amendment requires no further re= gulatory review. Please now share this amendment with your UK research site= s, in accordance with the instructions in your completed amendment tool. For studies with more than one UK research site, your amendment will now be= automatically shared with the R&D offices of any NHS/HSC research sites in= Scotland, but you should share the amendment by email directly with those = Research team/s. For all NHS research sites in England, Wales and Northern Ireland, please n= ow share this amendment by email directly with those sites, including both = the R&D offices and research teams. Do not reply to this email as this is an unmonitored address and replies to= this email cannot be responded to or read. ________________________________ This message may contain confidential information. If you are not the inten= ded recipient please inform the sender that you have received the message i= n error before deleting it. Please do not disclose, copy or distribute info= rmation in this e-mail or take any action in relation to its contents. To d= o so is strictly prohibited and may be unlawful. Thank you for your co-oper= ation.. ________________________________ --_000_LO0P302MB0209B0AFEC35D72FC5FFD4339046ALO0P302MB0209GBRP_ Content-Type: text/html; charset="us-ascii" Content-Transfer-Encoding: quoted-printable IRAS 316755. Amendment

¹û¶³´«Ã½


IRAS Project ID:              &n= bsp;             316755  
Sponsor amendment reference: NSA24 


Thank = you for submitting your study amendment.  In accordance with the outco= me of your completed amendment tool, this amendment requires no further regulatory review. Please now share this amendmen= t with your UK research sites, in accordance with the instructions in your = completed amendment tool.

For studies with more= than one UK research site, your amendment will now be automatically shared= with the R&D offices of any NHS/HSC research sites in Scotland, but yo= u should share the amendment by email directly with those Research team/s.

For all NHS researc= h sites in England, Wales and Northern Ireland, please now share this amend= ment by email directly with those sites, including both the R&D offices= and research teams.

Do not reply to this = email as this is an unmonitored address and replies to this email cannot be= responded to or read.

This message may contain confidential information. If you are not the inten= ded recipient please inform the sender that you have received the message i= n error before deleting it. Please do not disclose, copy or distribute info= rmation in this e-mail or take any action in relation to its contents. To do so is strictly prohibited and ma= y be unlawful. Thank you for your co-operation..
--_000_LO0P302MB0209B0AFEC35D72FC5FFD4339046ALO0P302MB0209GBRP_--